McKinsey Global Research declared the 21st Century the Biotech Century, where Biotech would economically impact 400 use cases, half of them outside of healthcare. The opportunity is hardly a question: in 2020 it was estimated that $3.1B was invested in alternative proteins while Synthetic Biology Companies raised $8B. Having worked with 100+ startups including some of the most well-known in the field, we will help a startup find market, communicate their technology, raise funds and establish a quality offering to investors.